Clinical Trials Browser

Phase 1 × Completed × Ferrosoferric Oxide × Clear all

NCT02631733 2025-02-10

Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Malignant Solid Neoplasm

NCT01770353 2019-11-27

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

Phase 1 Completed

45 enrolled 33 charts

BreastGastrointestinalGynecologicHead & Neck

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT01296139 2018-07-05

Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms